Guarantor Subsidiaries (Details) (USD $) In Thousands, unless otherwise specified	1 Months Ended		3 Months Ended																		12 Months Ended
	Jun. 30, 2011	Apr. 30, 2010	Dec. 31, 2012		Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012		Dec. 31, 2011		Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011		Dec. 31, 2010		Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010		Dec. 31, 2012		Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Guarantor Subsidiaries [Abstract]
Ownership percentage in domestic restricted subsidiaries (in hundredths)																					100.00%
Current assets:
Cash and cash equivalents (including restricted cash)			$ 35,875						$ 39,272						$ 41,029						$ 35,875		$ 39,272		$ 41,029
Accounts receivable, net			72,065						71,014						53,254						72,065		71,014		53,254
Intercompany receivables			0						0						0						0		0		0
Other current assets			35,707						33,988						21,480						35,707		33,988		21,480
Total current assets			143,647						144,274						115,763						143,647		144,274		115,763
Net property and equipment			4,964						4,391						5,772						4,964		4,391		5,772
Purchased and developed software, net			19,007						23,924						26,619						19,007		23,924		26,619
Other intangible assets, net			35,628						45,152						48,957						35,628		45,152		48,957
Goodwill			214,312						209,829						169,533						214,312		209,829		169,533		169,533
Investment in and advances to subsidiaries			0						0						0						0		0		0
Other assets			19,295						22,817						30,001						19,295		22,817		30,001
Total assets			436,853						450,387						396,645						436,853		450,387		396,645
Current liabilities:
Accounts payable			24,438						22,114						18,370						24,438		22,114		18,370
Deferred revenue			52,355						51,246						52,233						52,355		51,246		52,233
Intercompany payables			0						0						0						0		0		0
Other accrued liabilities			23,653						24,894						16,803						23,653		24,894		16,803
Total current liabilities			100,446						98,254						87,406						100,446		98,254		87,406
Notes payable			250,046						249,438						195,077						250,046		249,438		195,077
Other long-term liabilities			8,900						10,224						9,356						8,900		10,224		9,356
Total liabilities			359,392						357,916						291,839						359,392		357,916		291,839
Total shareholders' equity			77,461						92,471						104,806						77,461		92,471		104,806		68,137
Total liabilities and shareholders' equity			436,853						450,387						396,645						436,853		450,387		396,645
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Net sales			64,646		60,394	62,886	60,978		64,087		60,077	55,592	52,672		46,170		45,189	29,003	19,970		248,904		232,428		140,332
Cost of sales																					108,051		88,654		64,563
Gross margin			33,728		35,540	35,590	35,995		40,216		36,128	36,861	30,569		24,775		24,451	12,989	13,554		140,853		143,774		75,769
Selling, research and development, general and administrative expenses																					118,693		98,921		62,773
Acquisition-related expenses																					3,402		1,614		9,674
Restructuring and other expenses																					830		1,216		5,006
Depreciation, amortization and impairment																					11,308		12,868		6,840
Total operating costs and expenses																					134,233		114,619		84,293
Operating income (loss)																					6,620		29,155		(8,524)
Equity in net income of subsidiaries																					0		0		0
Other, net																					(31,349)		(31,021)		(16,638)
Other income (expense)																					(31,349)		(31,021)		(16,638)
Income (loss) before income taxes			(16,571)		(2,142)	(3,758)	(2,258)		(208)		(1,255)	341	(744)		(3,696)		(3,459)	(14,903)	(3,104)		(24,729)		(1,866)		(25,162)
Income tax expense (benefit)																					4,091		3,665		(13,646)
Net income (loss)			(17,252)		(3,826)	(5,879)	(1,863)		(1,244)		(1,013)	(1,685)	(1,589)		10,043		(3,446)	(14,961)	(3,152)		(28,820)		(5,531)		(11,516)
Cash flows from operating activities:
Net income (loss)			(17,252)		(3,826)	(5,879)	(1,863)		(1,244)		(1,013)	(1,685)	(1,589)		10,043		(3,446)	(14,961)	(3,152)		(28,820)		(5,531)		(11,516)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Deferred income taxes																					3,581		8,108		(14,056)
Depreciation, amortization and impairment																					20,295		22,208		17,812
Share-based compensation																					5,786		3,908		2,623
Change in contingent consideration for acquisitions																					1,380		345		113
Amortization of note payable issuance costs and discount																					2,724		2,393		1,445
Unrealized gain (loss) on investment																					(486)
Realized gain (loss) on investment																							(405)		(506)
Provision for doubtful accounts receivable and allowances, net of recoveries																					12,051		2,766		880
Stock issued for charitable contribution																					0		1,851		0
Net change in assets and liabilities (net of effects of acquisitions)																					(17,151)		(33,954)		9,210
Net cash provided by (used in) operating activities																					(640)		1,689		6,005
Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired																					(876)		(1,277)		(216,212)
Investment in securities																					(240)
Purchases of property, equipment, and leasehold improvements																					(2,174)		(1,976)		(1,492)
Proceeds from sale of property and equipment																					0		0		6,124
Intercompany advances																					0		0		0
Change in restricted cash																					(106)		940		(1,088)
Distribution from equity investment																							405		606
Net cash provided by (used in) investing activities																					(3,396)		(1,908)		(212,062)
Cash flows from financing activities:
Intercompany advances																					0		0		0
Proceeds from issuance of term notes																					0		53,560		194,532
Proceeds from issuance of stock		41,750																			0		0		41,750
Note and stock issuance costs paid																					0		(1,528)		(9,897)
Proceeds from exercise of stock options and employee stock purchase plan																					1,039		1,166		160
Principal payments on notes																					(37)		(4,591)		0
Repurchases of stock																					0		0		(26)
Principal payments on capital leases																					(396)		(4)		(142)
Redemption and retirement of preferred stock	41,750																				0		(41,750)		0
Preferred stock dividends																					0		(7,328)		0
Net cash provided by (used in) financing activities																					606		(475)		226,377
Effect of exchange rates on cash and cash equivalents																					(73)		(123)		0
Net increase (decrease) in cash and cash equivalents																					(3,503)		(817)		20,320
Cash and cash equivalents (net of restricted cash), beginning of period							38,565	[1],[2],[3],[4]					39,382	[1],[2],[5]					19,062	[1],[6]	38,565	[1],[2],[3],[4]	39,382	[1],[2],[5]	19,062	[1],[6]
Cash and cash equivalents (net of restricted cash), end of period			35,062	[2],[4]					38,565	[1],[2],[3],[4]					39,382	[1],[2],[5]					35,062	[2],[4]	38,565	[1],[2],[3],[4]	39,382	[1],[2],[5]
Restricted cash			813						707						1,647						813		707		1,647		559
Discount on notes payable															5,468										5,468
Parent [Member]
Current assets:
Cash and cash equivalents (including restricted cash)			862						5,451						870						862		5,451		870
Accounts receivable, net			0						0						0						0		0		0
Intercompany receivables			1,142						0						14,170						1,142		0		14,170
Other current assets			2,668						595						791						2,668		595		791
Total current assets			4,672						6,046						15,831						4,672		6,046		15,831
Net property and equipment			130						113						156						130		113		156
Purchased and developed software, net			0						0						601						0		0		601
Other intangible assets, net			0						0						395						0		0		395
Goodwill			0						0						0						0		0		0
Investment in and advances to subsidiaries			345,364						340,637						284,893						345,364		340,637		284,893
Other assets			5,957						8,013						13,615						5,957		8,013		13,615
Total assets			356,123						354,809						315,491						356,123		354,809		315,491
Current liabilities:
Accounts payable			1,509						3,124						2,054						1,509		3,124		2,054
Deferred revenue			0						0						0						0		0		0
Intercompany payables			20,008						2,176						0						20,008		2,176		0
Other accrued liabilities			4,352						4,921						4,965						4,352		4,921		4,965
Total current liabilities			25,869						10,221						7,019						25,869		10,221		7,019
Notes payable			250,046						249,371						195,077						250,046		249,371		195,077
Other long-term liabilities			2,747						2,746						8,589						2,747		2,746		8,589
Total liabilities			278,662						262,338						210,685						278,662		262,338		210,685
Total shareholders' equity			77,461						92,471						104,806						77,461		92,471		104,806
Total liabilities and shareholders' equity			356,123						354,809						315,491						356,123		354,809		315,491
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Net sales																					0		0		0
Cost of sales																					0		0		0
Gross margin																					0		0		0
Selling, research and development, general and administrative expenses																					12,532		3,455		5,819
Acquisition-related expenses																					3,402		1,614		9,638
Restructuring and other expenses																					0		0		418
Depreciation, amortization and impairment																					59		279		858
Total operating costs and expenses																					15,993		5,348		16,733
Operating income (loss)																					(15,993)		(5,348)		(16,733)
Equity in net income of subsidiaries																					9,689		30,476		22,502
Other, net																					(22,515)		(30,889)		(17,097)
Other income (expense)																					(12,826)		(413)		5,405
Income (loss) before income taxes																					(28,819)		(5,761)		(11,328)
Income tax expense (benefit)																					1		(230)		188
Net income (loss)																					(28,820)		(5,531)		(11,516)
Cash flows from operating activities:
Net income (loss)																					(28,820)		(5,531)		(11,516)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Deferred income taxes																					0		3,368		(2)
Depreciation, amortization and impairment																					59		1,038		2,221
Share-based compensation																					2,944		1,837		1,350
Change in contingent consideration for acquisitions																					1,547		0		0
Amortization of note payable issuance costs and discount																					2,724		2,393		1,445
Unrealized gain (loss) on investment																					(486)
Realized gain (loss) on investment																							0		0
Provision for doubtful accounts receivable and allowances, net of recoveries																					0		0		0
Stock issued for charitable contribution																							1,851
Net change in assets and liabilities (net of effects of acquisitions)																					(3,180)		(43,694)		(21,541)
Net cash provided by (used in) operating activities																					(25,212)		(38,738)		(28,043)
Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired																					0		0		(211,367)
Investment in securities																					0
Purchases of property, equipment, and leasehold improvements																					(75)		0		(139)
Proceeds from sale of property and equipment																									0
Intercompany advances																					0		0		8,518
Change in restricted cash																					(106)		140		(415)
Distribution from equity investment																							0		0
Net cash provided by (used in) investing activities																					(181)		140		(203,403)
Cash flows from financing activities:
Intercompany advances																					19,658		39,199		0
Proceeds from issuance of term notes																							53,560		194,532
Proceeds from issuance of stock																									41,750
Note and stock issuance costs paid																							(1,528)		(9,897)
Proceeds from exercise of stock options and employee stock purchase plan																					1,039		1,166		160
Principal payments on notes																					0		0
Repurchases of stock																									(26)
Principal payments on capital leases																					0		0		0
Redemption and retirement of preferred stock																							(41,750)
Preferred stock dividends																							(7,328)
Net cash provided by (used in) financing activities																					20,697		43,319		226,519
Effect of exchange rates on cash and cash equivalents																					0		0
Net increase (decrease) in cash and cash equivalents																					(4,695)		4,721		(4,927)
Cash and cash equivalents (net of restricted cash), beginning of period							4,907						186						5,113		4,907		186		5,113
Cash and cash equivalents (net of restricted cash), end of period			212						4,907						186						212		4,907		186
Guarantors [Member]
Current assets:
Cash and cash equivalents (including restricted cash)			32,012						28,003						35,877						32,012		28,003		35,877
Accounts receivable, net			61,871						63,487						48,201						61,871		63,487		48,201
Intercompany receivables			48,418						29,108						14,168						48,418		29,108		14,168
Other current assets			29,337						29,579						16,766						29,337		29,579		16,766
Total current assets			171,638						150,177						115,012						171,638		150,177		115,012
Net property and equipment			4,187						3,753						4,949						4,187		3,753		4,949
Purchased and developed software, net			18,508						23,309						25,210						18,508		23,309		25,210
Other intangible assets, net			35,025						44,483						48,053						35,025		44,483		48,053
Goodwill			212,908						207,799						167,957						212,908		207,799		167,957
Investment in and advances to subsidiaries			(868)						(338)						1,830						(868)		(338)		1,830
Other assets			5,745						4,597						7,164						5,745		4,597		7,164
Total assets			447,143						433,780						370,175						447,143		433,780		370,175
Current liabilities:
Accounts payable			21,839						17,647						14,155						21,839		17,647		14,155
Deferred revenue			50,716						49,678						50,573						50,716		49,678		50,573
Intercompany payables			13,369						8,580						13,767						13,369		8,580		13,767
Other accrued liabilities			18,168						18,729						10,902						18,168		18,729		10,902
Total current liabilities			104,092						94,634						89,397						104,092		94,634		89,397
Notes payable			0						67						0						0		67		0
Other long-term liabilities			5,518						6,381						2,785						5,518		6,381		2,785
Total liabilities			109,610						101,082						92,182						109,610		101,082		92,182
Total shareholders' equity			337,532						332,698						277,993						337,532		332,698		277,993
Total liabilities and shareholders' equity			447,143						433,780						370,175						447,143		433,780		370,175
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Net sales																					225,662		206,144		122,001
Cost of sales																					104,117		83,782		59,511
Gross margin																					121,545		122,362		62,490
Selling, research and development, general and administrative expenses																					92,670		80,130		50,634
Acquisition-related expenses																					0		0		36
Restructuring and other expenses																					425		1,061		4,575
Depreciation, amortization and impairment																					10,990		12,251		5,665
Total operating costs and expenses																					104,085		93,442		60,910
Operating income (loss)																					17,460		28,920		1,580
Equity in net income of subsidiaries																					(2,507)		(1,546)		(138)
Other, net																					(10,395)		(398)		106
Other income (expense)																					(12,902)		(1,944)		(32)
Income (loss) before income taxes																					4,558		26,976		1,548
Income tax expense (benefit)																					1,741		1,830		200
Net income (loss)																					2,817		25,146		1,348
Cash flows from operating activities:
Net income (loss)																					2,817		25,146		1,348
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Deferred income taxes																					1,179		2,693		0
Depreciation, amortization and impairment																					19,847		20,793		14,762
Share-based compensation																					2,695		1,987		1,121
Change in contingent consideration for acquisitions																					(167)		345		113
Amortization of note payable issuance costs and discount																					0		0		0
Unrealized gain (loss) on investment																					0
Realized gain (loss) on investment																							0		0
Provision for doubtful accounts receivable and allowances, net of recoveries																					12,561		2,102		400
Stock issued for charitable contribution																							0
Net change in assets and liabilities (net of effects of acquisitions)																					(13,927)		(13,393)		11,487
Net cash provided by (used in) operating activities																					25,006		39,673		29,231
Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired																					(876)		(1,277)		(4,845)
Investment in securities																					(240)
Purchases of property, equipment, and leasehold improvements																					(1,846)		(1,952)		(1,220)
Proceeds from sale of property and equipment																									6,124
Intercompany advances																					(17,638)		(39,723)		0
Change in restricted cash																					0		800		(673)
Distribution from equity investment																							0		0
Net cash provided by (used in) investing activities																					(20,600)		(42,152)		(614)
Cash flows from financing activities:
Intercompany advances																					0		0		(2,353)
Proceeds from issuance of term notes																							0		0
Proceeds from issuance of stock																									0
Note and stock issuance costs paid																							0		0
Proceeds from exercise of stock options and employee stock purchase plan																					0		0		0
Principal payments on notes																					0		(4,591)
Repurchases of stock																									0
Principal payments on capital leases																					(396)		(4)		(142)
Redemption and retirement of preferred stock																							0
Preferred stock dividends																							0
Net cash provided by (used in) financing activities																					(396)		(4,595)		(2,495)
Effect of exchange rates on cash and cash equivalents																					0		0
Net increase (decrease) in cash and cash equivalents																					4,009		(7,074)		26,122
Cash and cash equivalents (net of restricted cash), beginning of period							27,840						34,914						8,792		27,840		34,914		8,792
Cash and cash equivalents (net of restricted cash), end of period			31,849						27,840						34,914						31,849		27,840		34,914
Non-Guarantors [Member]
Current assets:
Cash and cash equivalents (including restricted cash)			3,001						5,818						4,282						3,001		5,818		4,282
Accounts receivable, net			10,194						7,527						5,053						10,194		7,527		5,053
Intercompany receivables			799						635						961						799		635		961
Other current assets			3,702						3,814						3,923						3,702		3,814		3,923
Total current assets			17,696						17,794						14,219						17,696		17,794		14,219
Net property and equipment			648						525						667						648		525		667
Purchased and developed software, net			499						615						808						499		615		808
Other intangible assets, net			603						669						509						603		669		509
Goodwill			1,404						2,030						1,576						1,404		2,030		1,576
Investment in and advances to subsidiaries			0						0						0						0		0		0
Other assets			7,593						9,835						12,101						7,593		9,835		12,101
Total assets			28,443						31,468						29,880						28,443		31,468		29,880
Current liabilities:
Accounts payable			1,090						1,343						2,161						1,090		1,343		2,161
Deferred revenue			1,639						1,568						1,660						1,639		1,568		1,660
Intercompany payables			17,037						24,086						25,580						17,037		24,086		25,580
Other accrued liabilities			1,133						1,244						936						1,133		1,244		936
Total current liabilities			20,899						28,241						30,337						20,899		28,241		30,337
Notes payable			0						0						0						0		0		0
Other long-term liabilities			635						725						861						635		725		861
Total liabilities			21,534						28,966						31,198						21,534		28,966		31,198
Total shareholders' equity			6,909						2,502						(1,318)						6,909		2,502		(1,318)
Total liabilities and shareholders' equity			28,443						31,468						29,880						28,443		31,468		29,880
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Net sales																					23,242		26,284		18,331
Cost of sales																					3,934		4,872		5,052
Gross margin																					19,308		21,412		13,279
Selling, research and development, general and administrative expenses																					13,491		15,336		6,320
Acquisition-related expenses																					0		0		0
Restructuring and other expenses																					405		155		13
Depreciation, amortization and impairment																					259		338		317
Total operating costs and expenses																					14,155		15,829		6,650
Operating income (loss)																					5,153		5,583		6,629
Equity in net income of subsidiaries																					0		0		0
Other, net																					1,561		266		353
Other income (expense)																					1,561		266		353
Income (loss) before income taxes																					6,714		5,849		6,982
Income tax expense (benefit)																					2,349		2,065		(14,034)
Net income (loss)																					4,365		3,784		21,016
Cash flows from operating activities:
Net income (loss)																					4,365		3,784		21,016
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Deferred income taxes																					2,402		2,047		(14,054)
Depreciation, amortization and impairment																					389		377		829
Share-based compensation																					147		84		152
Change in contingent consideration for acquisitions																					0		0		0
Amortization of note payable issuance costs and discount																					0		0		0
Unrealized gain (loss) on investment																					0
Realized gain (loss) on investment																							(405)		(506)
Provision for doubtful accounts receivable and allowances, net of recoveries																					(510)		664		480
Stock issued for charitable contribution																							0
Net change in assets and liabilities (net of effects of acquisitions)																					(7,227)		(5,797)		(3,100)
Net cash provided by (used in) operating activities																					(434)		754		4,817
Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired																					0		0		0
Investment in securities																					0
Purchases of property, equipment, and leasehold improvements																					(253)		(24)		(133)
Proceeds from sale of property and equipment																									0
Intercompany advances																					(2,520)		0		0
Change in restricted cash																					0		0		0
Distribution from equity investment																							405		606
Net cash provided by (used in) investing activities																					(2,773)		381		473
Cash flows from financing activities:
Intercompany advances																					500		524		(6,165)
Proceeds from issuance of term notes																							0		0
Proceeds from issuance of stock																									0
Note and stock issuance costs paid																							0		0
Proceeds from exercise of stock options and employee stock purchase plan																					0		0		0
Principal payments on notes																					(37)		0
Repurchases of stock																									0
Principal payments on capital leases																					0		0		0
Redemption and retirement of preferred stock																							0
Preferred stock dividends																							0
Net cash provided by (used in) financing activities																					463		524		(6,165)
Effect of exchange rates on cash and cash equivalents																					(73)		(123)
Net increase (decrease) in cash and cash equivalents																					(2,817)		1,536		(875)
Cash and cash equivalents (net of restricted cash), beginning of period							5,818						4,282						5,157		5,818		4,282		5,157
Cash and cash equivalents (net of restricted cash), end of period			3,001						5,818						4,282						3,001		5,818		4,282
Eliminations [Member]
Current assets:
Cash and cash equivalents (including restricted cash)			0						0						0						0		0		0
Accounts receivable, net			0						0						0						0		0		0
Intercompany receivables			(50,359)						(29,743)						(29,299)						(50,359)		(29,743)		(29,299)
Other current assets			0						0						0						0		0		0
Total current assets			(50,359)						(29,743)						(29,299)						(50,359)		(29,743)		(29,299)
Net property and equipment			0						0						0						0		0		0
Purchased and developed software, net			0						0						0						0		0		0
Other intangible assets, net			0						0						0						0		0		0
Goodwill			0						0						0						0		0		0
Investment in and advances to subsidiaries			(344,496)						(340,299)						(286,723)						(344,496)		(340,299)		(286,723)
Other assets			0						372						(2,879)						0		372		(2,879)
Total assets			(394,855)						(369,670)						(318,901)						(394,855)		(369,670)		(318,901)
Current liabilities:
Accounts payable			0						0						0						0		0		0
Deferred revenue			0						0						0						0		0		0
Intercompany payables			(50,414)						(34,842)						(39,347)						(50,414)		(34,842)		(39,347)
Other accrued liabilities			0						0						0						0		0		0
Total current liabilities			(50,414)						(34,842)						(39,347)						(50,414)		(34,842)		(39,347)
Notes payable			0						0						0						0		0		0
Other long-term liabilities			0						372						(2,879)						0		372		(2,879)
Total liabilities			(50,414)						(34,470)						(42,226)						(50,414)		(34,470)		(42,226)
Total shareholders' equity			(344,441)						(335,200)						(276,675)						(344,441)		(335,200)		(276,675)
Total liabilities and shareholders' equity			(394,855)						(369,670)						(318,901)						(394,855)		(369,670)		(318,901)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Net sales																					0		0		0
Cost of sales																					0		0		0
Gross margin																					0		0		0
Selling, research and development, general and administrative expenses																					0		0		0
Acquisition-related expenses																					0		0		0
Restructuring and other expenses																					0		0		0
Depreciation, amortization and impairment																					0		0		0
Total operating costs and expenses																					0		0		0
Operating income (loss)																					0		0		0
Equity in net income of subsidiaries																					(7,182)		(28,930)		(22,364)
Other, net																					0		0		0
Other income (expense)																					(7,182)		(28,930)		(22,364)
Income (loss) before income taxes																					(7,182)		(28,930)		(22,364)
Income tax expense (benefit)																					0		0		0
Net income (loss)																					(7,182)		(28,930)		(22,364)
Cash flows from operating activities:
Net income (loss)																					(7,182)		(28,930)		(22,364)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Deferred income taxes																					0		0		0
Depreciation, amortization and impairment																					0		0		0
Share-based compensation																					0		0		0
Change in contingent consideration for acquisitions																					0		0		0
Amortization of note payable issuance costs and discount																					0		0		0
Unrealized gain (loss) on investment																					0
Realized gain (loss) on investment																							0		0
Provision for doubtful accounts receivable and allowances, net of recoveries																					0		0		0
Stock issued for charitable contribution																							0
Net change in assets and liabilities (net of effects of acquisitions)																					7,182		28,930		22,364
Net cash provided by (used in) operating activities																					0		0		0
Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired																					0		0		0
Investment in securities																					0
Purchases of property, equipment, and leasehold improvements																					0		0		0
Proceeds from sale of property and equipment																									0
Intercompany advances																					20,158		39,723		(8,518)
Change in restricted cash																					0		0		0
Distribution from equity investment																							0		0
Net cash provided by (used in) investing activities																					20,158		39,723		(8,518)
Cash flows from financing activities:
Intercompany advances																					(20,158)		(39,723)		8,518
Proceeds from issuance of term notes																							0		0
Proceeds from issuance of stock																									0
Note and stock issuance costs paid																							0		0
Proceeds from exercise of stock options and employee stock purchase plan																					0		0		0
Principal payments on notes																					0		0
Repurchases of stock																									0
Principal payments on capital leases																					0		0		0
Redemption and retirement of preferred stock																							0
Preferred stock dividends																							0
Net cash provided by (used in) financing activities																					(20,158)		(39,723)		8,518
Effect of exchange rates on cash and cash equivalents																					0		0
Net increase (decrease) in cash and cash equivalents																					0		0		0
Cash and cash equivalents (net of restricted cash), beginning of period							0						0						0		0		0		0
Cash and cash equivalents (net of restricted cash), end of period			$ 0						$ 0						$ 0						$ 0		$ 0		$ 0

[1] Net of restricted cash of $1,647, $559, and $621 at December 31, 2011, 2010, and 2009, respectively.

[2] Net of restricted cash of $813, $707, and $1,647 at December 31, 2012, 2011 and 2010, respectively.

[3] Net of restricted cash of $707 at December 31, 2011.

[4] Net of restricted cash of $813 at December 31, 2012

[5] Net of restricted cash of $1,647 at December 31, 2010.

[6] Net of restricted cash of $559 at December 31, 2009.